Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × bicalutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 22 Triple Negative Breast Neoplasms 2 Prostate Adenocarcinoma 2 Breast Neoplasms 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Salivary Gland Neoplasms 1 Primary Dysautonomias 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Kidney Diseases 1 Hypertension 1 Glioma 1 Glioblastoma 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡